Dec 21, 2018 by Motley Fool StaffOur Top Stock Idea in China’s Biotech RevolutionWhether you're in the U.S. or China, immuno-oncology is one of the hottest areas in biotech right now.
Dec 19, 2018 by Asit Sharma, CPAiRobot Cleans Up the CompetitionTariffs could hit the vacuum company hard, but iRobot’s long-term future still shines, especially when big data comes into the mix.
Dec 18, 2018 by Matt Frankel, CFPRobinhood's New Bank Accounts, Retirement Security, and a Fintech Insider Gives His InsightIs a 3% yield on savings too good to be true? Also, what can people do if their retirement savings aren't quite on track?
Dec 18, 2018 by Motley Fool StaffTake-Two’s Red Dead Redemption 2 Has Smashed RecordThe game has sold more than 17 million units since its October launch.
Dec 18, 2018 by Motley Fool StaffHow Amazon’s Alexa Stole ChristmasThe company’s Echo devices and Fire sticks were huge sellers during the Thanksgiving sales period.
Dec 18, 2018 by Motley Fool StaffNintendo Switch Has Arrived as a Major PlayerThe console has been a fast seller, and it’s a clear rival for Xbox One and PlayStation 4.
Dec 18, 2018 by Motley Fool StaffIs Moderna’s Huge IPO in 2018 Worth the Hype?Here’s what you should know about the public offering of this biotech unicorn this year.
Dec 18, 2018 by Motley Fool StaffThis Could Be the Biggest Marijuana News in 2018Canada’s landmark recreational marijuana market opening overshadowed this important advance.
Dec 18, 2018 by Motley Fool StaffHere Are Biotech’s Big Pipeline Disappointments in 2018A number of companies suffered setbacks this year.
Dec 18, 2018 by Motley Fool StaffRNAi Goes Big-Time in 2018A first-in-kind FDA approval catapulted this treatment approach into the spotlight.
Dec 18, 2018 by Motley Fool StaffImmuno-Oncology Suffered a Setback in 2018. What’s Next?Checkpoint inhibitors remain top sellers, but it wasn’t all rosy news this year.
Dec 18, 2018 by Motley Fool StaffWhat Happened With CAR-T Stocks in 2018Here’s how CAR-T therapies did in their first full year on the market.
Dec 17, 2018 by Daniel B. KlineHow Nintendo Got Its Groove BackNintendo was on the brink of some pretty crushing failure, but this holiday season shows it turned things back around.
Dec 15, 2018 by Daniel B. KlineHow the Logistics Industry WorksBetween spiking online shopping, tariff-driven inventory debacles, USPS rate increases, and more, the logistics world is getting more complicated.
Dec 13, 2018 by Todd CampbellTop 10 Healthcare Stories of 2018New drugs, trial flops, M&A, and a little bit of everything else that happened in healthcare in 2018.
Dec 12, 2018 by Daniel B. KlineKeurig Dr. Pepper After the Merge -- Where Are They Now?The new coffee-soda medley company has started to carve out its own space, but it still has plenty of work to do.
Dec 12, 2018 by Matt Frankel, CFPThe Volatile Stock Market and a New Approach to Teaching Students to InvestWhen will the stock market volatility end, and what do investors need to know about it?
Dec 10, 2018 by Evan Niu, CFALyft Races Ahead With Its IPOLyft will probably beat Uber to the public markets, but Alphabet beat them both in the semi-autonomous race.
Dec 7, 2018 by John RosevearMicromobility 101 for InvestorsScooter- and bike-sharing companies are popping up in cities. Here’s what investors should know about this trend that’s only getting bigger.
Dec 6, 2018 by Todd Campbell3 Top Stocks After #ASH18Positive trial data unveiled at the American Society of Hematology conference makes these top stocks to watch in 2019.
